Doctor reacts to AI breast cancer tool

The providers of Clairity Breast, a new FDA-approved AI tool, claim their tech provides an accurate five-year risk assessment for breast cancer, for just $249. Dr. Céline Gounder shares her thoughts.

Read the full story at CBS News Technology ↗

Timeline · 1 report

2026-10-16 13:47 · CBS News Technology
Doctor reacts to AI breast cancer tool

More stories

Meta and Apple collaborate to enable Muse Spark Open AI model on Macs — Wall Street Journal Technology
Reflection AI releases Beam, a 501B open-weight model for agentic coding — AWS Machine Learning Blog
NVIDIA RTX Spark Laptops Launch Globally With Local AI Agent Support — NVIDIA Blog
Google Gemini 4 Argon demonstrates advanced robotics and reasoning capabilities — Google DeepMind YouTube
Epic Games releases new launcher built with AI assistance — Ars Technica AI
Reviews Assess Nvidia RTX Spark in Microsoft Surface Laptop Ultra — Techmeme
Meta releases 816B open-weight Muse Spark model; NVIDIA updates Nemotron — AWS Machine Learning Blog
Closing the Binary Blind Spot: Domain-Knowledge Injection for LLM Malware Triage in npm Packages — Databricks Blog

Get the daily brief of stories like this at 6:30 every morning →